Clonidine (imino form) is a clonidine. It exists as a tautomer of a clonidine (amino form). Clonidine is an imidazole derivate that functions as a agonist of alpha-2 adrenoceptors. This activity is useful for the treatment of hypertension, severe pain, and ADHD. Clonidine was granted FDA approval on 3 September 1974. Clonidine is a Central alpha-2 Adrenergic Agonist. The mechanism of action of clonidine is as an Adrenergic alpha2-Agonist. It is grouped under the following drug class(es): Alpha-2 agonists, Opioid dependence agents and Spasticity agents. Its therapeutic use is listed as ADHD agents, antidiarrheals, antihypertensives and smoking cessation agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Adesipress, Catarpres and Catarpresan. Its PubChem CID is 2803.
Clonidine
| CAS No | 4205-90-7 |
|---|---|
| Molecular Formula | C9H9Cl2N3 |
| Molecular Weight | 230.09 g/mol |
| Synonyms | N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Clonidine (imino form) is a clonidine. It exists as a tautomer of a clonidine (amino form). Clonidine is an imidazole derivate that functions as a agonist of alpha-2 adrenoceptors.
The listed CAS number is 4205-90-7.
The listed molecular formula is C9H9Cl2N3.
The listed molecular weight is 230.09 g/mol.
N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine.
The source lists Adesipress, Catarpres and Catarpresan.